Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
ANG II contributes importantly to the regulation of renal vascular resistance, glomerular filtration, and tubular epithelial transport, yet there remains a paucity of information regarding the localization of the ANG II type 1 and 2 (AT1 and AT2) receptors within the rat kidney particularly within the vasculature. The present study was designed to localize the transcriptional and translational site(s) of AT1 and AT2 receptor (AT1R and AT2R, respectively) expression within the rat kidney. Using immunohistochemistry, we detected the AT1R translational sites throughout the kidney, with the strongest labeling found in the vasculature of the renal cortex and the proximal tubules of the outer medulla. The AT2R protein expression was found throughout the rat kidney, although there was little to no expression found in the glomerulus and medullary thick ascending limbs of Henle (TAL). Gene-specific primers were then designed to distinguish between the receptor subtypes within microdissected renal tubular and vascular segments using RT-PCR. AT1AR, AT1BR, and AT2R mRNA were found within the renal vasculature (afferent arterioles, arcuate artery, and outer medullary descending vasa recta). The mRNA for both the AT1R isoforms was also detected in the glomeruli and the renal tubules (proximal tubules, TAL, and collecting ducts); however, no AT2R mRNA was detected within the glomerulus and was inconsistently found within the medullary TAL (MTAL). Taken together, these data show that mRNA for the AT1R subtypes was located in all of the renal tubular and vascular segments. Evidence for AT2R mRNA was also found in all but two of the vascular and tubular segments, the MTAL, and the glomeruli. These results are consistent with the whole tissue immunohistochemically localized receptors.
reverse transcription-polymerase chain reaction; immunohistochemistry; kidney; microdissection
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
TWO TYPES of angiotensin II (ANG II) receptors were pharmacologically described in 1993 and classified as the AT1 and AT2 receptors (AT1R and AT2R, respectively) (40). More recently, the cDNAs that encode the AT1R were cloned and led to the discovery of two distinct AT1R subtypes, which were defined as the AT1AR and AT1BR (12, 14, 33). Interestingly, although it was found that these AT1R subtype genes were located on different chromosomes, they exhibited over 90% homology in the coding region of the cDNA sequence, and 95% homology at the amino acid level (14). In contrast, the coding region of the AT1R and AT2R cDNA sequences exhibit only 30% homology (16, 17).
The predominant biological effects of ANG II are believed to be mediated through the stimulation of AT1R subtypes that mediate vasoconstriction (4), angiogenesis (41), and stimulation of sodium and water reabsorption in the proximal tubules (18). To determine the whole tissue distribution of the AT1R subtypes, several investigators have used RT-PCR (15, 19) and in situ hybridization (22). These studies have demonstrated AT1R mRNA throughout the kidney with the highest abundance in the outer medulla as determined by in situ hybridization (22) and semiquantitative RT-PCR (19).
At the present time, both the localization and the functional role of each of the isoforms of the AT1R subtypes within the rat kidney remain unclear. The AT1AR is believed to play the major role in the renal actions of ANG II, but little is known about the intrarenal role of the AT1BR subtype. Recent studies in the systemic circulation suggest that the AT1BR may play a role similar to the AT1AR (27), but neither renal vascular nor tubular actions of this receptor isoform have been explored. Even the localization of the AT1R isoforms within distinct segments of the renal tubular and vascular system has remained unclear, since it has been difficult to design specific PCR primers for the AT1R isoforms due to the high degree of homology of the AT1AR and AT1BR.
A paucity of information also exists about the localization of the AT2R within the kidney. In situ hybridization studies by Shanmugam et al. (36) initially suggested that the expression of the AT2 mRNA was developmentally regulated within the rat kidney, since AT2R mRNA was detectable only in fetal and immature rats. More recently, Ozono et al. (28) reported AT2R expression in glomeruli and distal tubules of adult rats. In addition, functional studies have provided pharmacological evidence that the AT2R can influence renal function. Lo et al. (20) observed that the pressure-natriuresis relationship in rats was enhanced by AT2R inhibition. Other investigators have reported AT2R involvement in prostaglandin-dependent and -independent vasodilation (13, 38). These studies suggest that AT2R receptors are present within the adult rat kidney and play a role in influencing renal function.
Because of the limited information regarding ANG II receptor distribution within the rat kidney, the aim of the present study was to design specific PCR primers for each of the ANG II receptor isoforms and localize the site(s) of transcription for the AT1R (AT1AR and AT1BR) and AT2R by RT-PCR in isolated renal tubules and blood vessels. In addition, the site(s) of translation for the AT1R and AT2R protein were assessed using immunohistochemical techniques.
![]() |
METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Experimental Animals
Male Sprague-Dawley rats weighing 80-120 g (5-6 wk old) from Sasco (Madison, WI), which were given free access to tap water and fed a standard pellet diet (Purina Mills, St. Louis, MO), were used in all studies. All protocols were approved by the Institutional Animal Care Committee, and rats were maintained in the American Association for Accreditation of Laboratory Animal Care approved Animal Resource Center of the Medical College of Wisconsin.Protein Isolation and Western Blot Analysis of AT1R and AT2R Antibody
Rat kidney (n = 3) plasma membrane-enriched fractions were isolated as previously described (30). In brief, kidneys were homogenized, and the homogenate was centrifuged at 3,000 g for 5 min and then at 16,000 g for 20 min. The pellet was resuspended and frozen at 80°C for use in Western blot analysis. A 5-µg (for AT2R) or 25-µg (for AT1R) aliquot was placed in sample buffer [2% SDS, 100 mM Tris · HCl, pH 6.8, 5%Immunohistochemistry for AT1R and AT2R Within the Rat Kidney
Rat kidneys (n = 6) were fixed in 10% Formalin and subsequently embedded in paraffin. Kidney sections (5 µm) were prepared, and sections were incubated with xylene and hydrated through several washes in ethanol and water to remove the paraffin. Endogenous peroxidase activity was quenched by the addition of 0.3% (vol/vol) hydrogen peroxide in methanol for 10 min. Polyclonal anti-rabbit AT1R (Santa Cruz Biotech, Santa Cruz, CA) or a polyclonal anti-rabbit AT2R antibody [generously provided by Dr. A. S. Greene and described previously by Nora et al. (26)] was used for the immunostaining. The antibodies were used at a dilution of 1:100 in 1% BSA in PBS (pH 7.2). The kidney sections were incubated for 45 min with the primary antibody at room temperature in a wet chamber. The specificity of the staining was determined by reacting the antibody with a 10-fold (by weight) excess of control antigenic peptide in PBS, which was incubated with the sections for 2 h at room temperature. Secondary antibody (donkey anti-goat) was incubated with the sections for 30 min followed by a complex of streptavidin and biotinylated peroxidase (DAKO, Bucks, UK). The immunoreactivity was detected by the addition of 0.5 mg/ml diaminobenzidine (Sigma, St. Louis, MO) and 0.01% hydrogen peroxide in PBS. Between each step, the sections were washed three times with 200 ml PBS over a period of 15 min. The sections were counterstained with Mayer's hematoxylin, dehydrated, and mounted.Preparation of Glomeruli, Renal Tubules, and Renal Microvessels
Rats (n = 6) were injected with 5 mg ip furosemide and 30 min later were anesthetized with a mixture of ketamine (50 mg/kg) and acepromazine (5 mg/kg) mixture given intramuscularly. Renal tubules and microvessels were isolated as previously described (30, 42). In brief, the left kidney was perfused with 10 ml dissection solution (DS) prewarmed to 37°C. Following kidney perfusion with DS, 1.0 ml of 2.5% latex-coated blue-dyed microparticles (~1-4 µm in diameter; Polysciences, Warrington, PA) were perfused into the left kidneys. The renal pedicle was ligated, and the kidney was excised and cut into coronal slices (~1-2 mm thick). These tissue slices were placed into DS containing 1 mg/ml collagenase (192 U/mg; Worthington Biochemical, Freehold, NJ), and incubated at 37°C for 35-40 min. For the isolation of inner medullary collecting ducts, the tissue was incubated in collagenase for longer periods (up to 60 min). After collagenase treatment, the tissue slices were rinsed with DS, and placed into a microdissection dish for tubules and microvessel isolation using a Leica M3Z stereomicroscope (magnification ×16-100). The following intrarenal blood vessels were dissected from the tissue slices: arcuate artery, afferent arterioles, glomeruli, and outer medullary descending vasa recta (OMDVR) from vascular bundles. For the renal tubules, proximal convoluted tubules, thick ascending limbs of Henle (TAL), and the collecting ducts (cortex and outer and inner medulla) were isolated as previous described (42). All lengths of the vessels were measured by a calibrated eyepiece micrometer, and for each RT reaction, 40 glomeruli, 40 mm of blood vessels, and 40 mm of renal tubules were isolated. Contaminating debris was rinsed from the dissected vessels, tubules, and glomeruli in a separate wash dish before transfer to an RNase-free ultracentrifuge tube containing 100 µl TRIzol reagent (GIBCO-BRL; Life Technologies, Gaithersburg, MD). The total RNA was extracted and treated with DNase solution as previously described (30). As a negative control for the presence of AT1B and AT2 mRNA, liver mRNA was run in parallel with the isolated tubular and microvascular total RNA.Preparation of Oligonucleotide Primers
All nucleotide primers were purchased from Operon Technologies (Alameda, CA). Oligonucleotide primers were chosen from the published cDNA sequences of angiotensin AT1AR (12), AT1BR (8), and AT2R (17). The primers for the AT2R spanned both introns found in the genomic DNA sequence, which allowed for differentiation of genomic DNA contamination, but the AT1A and AT1B PCR primers were not intron spanning.The primer sequence for the angiotensin AT1AR corresponded to 5'-CGT CAT CCA TGA CTG TAA AAT TTC-3' (sense; bp 1097-1120) and 5'-GGG CAT TAC ATT GCC AGT GTG-3' (antisense; bp 1381-1402). The final PCR product was 306 bp in size.
The primer sequence for the angiotensin AT1BR corresponded to 5'-CAT TAT CCG TGA CTG TGA AAT TG-3' (sense; bp 1369-1391) and 5'-GCT GCT TAG CCC AAA TGG TCC-3' (antisense; bp 1712-1732). The final PCR product was 344 bp in size.
The primer sequence for the angiotensin AT2R corresponded to 5'-GGA GCG AGC ACA GAA TTG AAA GC-3' (sense; bp 1586-1608) and 5'-TGC CCA GAG AGG AAG GGT TGC C-3' (antisense; bp 3332-3353). The final PCR product was 445 bp in size.
Reverse Transcription-Polymerase Chain Reaction
The RT-PCR assay was performed as previously described (30) with minor modifications to optimize the conditions for the primers in PCR. Briefly, 7-µl aliquots of the RT reaction products were used in the PCR assay, and the reaction mixtures were initially denatured at 94°C for 5 min and then cycled 35 times between 94°C (denaturation) for 1 min, 64°C (annealing), and 72°C (extension) for 1 min. Samples were incubated for an additional 7 min at 72°C after the completion of the final cycle. Three negative controls were used in each of the PCR reactions: RT-PCR of the DS, PCR amplification of sterile water, and PCR amplification of DNase-treated RNA to determine genomic DNA contamination.PCR Product Analysis
From each PCR reaction, 10-µl aliquots were electrophoretically size-fractionated on a 1.6% agarose gel. After electrophoresis and ethidium bromide staining, DNA bands were visualized with an ultraviolet transilluminator. To verify the authenticity of the PCR products, restriction enzyme analysis of the PCR products was performed, and the RT-PCR products were subsequently ligated into pCR2.1 vector (Invitrogen, San Diego, CA). The cloned plasmid DNA was purified using ion-exchange columns (QIAGEN, Chatsworth, CA), and the authenticity of the DNA insert was determined by sequencing with ThermoSequenase using the dideoxynucleotide-chain termination reaction (Amersham). The samples were resolved on a DNA sequencer 725 (Molecular Dynamics). ![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Angiotensin AT1 Receptor
Immunohistochemistry of
AT1R in the rat kidney.
The results from the immunohistochemistry for the
AT1R are from six different rat
kidneys, which were sectioned and examined. The
AT1R antibody produced a single
band at ~43 kDa on Western blot analysis, which is the expected size
of the AT1R and consistent with
the results of a previous study by Paxton et al. (31) using an antibody
directed against the same receptor sequence. Using this
AT1R antibody for
immunohistochemistry, we found the protein translational sites of the
AT1R to be localized throughout
the kidney, with the most intense region being the outer medulla (Fig. 1A).
Higher magnification of renal cortex and medulla revealed that the
strongest labeling of the AT1R was
found within the vasculature of the renal cortex (Fig.
1B) and the proximal
straight tubules (S3 segment) of the outer medulla (Fig.
1C). Lesser staining of the
AT1R was detected in the cortical
and outer medullary collecting ducts and TAL. Some immunolabeling was
found within the glomerulus (Fig.
1B), which is consistent with
previous studies by Paxton et al. (31) and Harrison-Bernard et al. (9),
who observed glomerular staining in mesangial cells and podocytes with
dense staining of the macula densa. In addition, there was light
labeling associated with the vascular bundles in the outer medulla,
which contain both the thin limbs of Henle's loop and vasa recta. The kidney sections that were incubated with the
AT1R antibody preadsorbed with the
competing antigenic peptide did not have any labeling, demonstrating
the specificity of the binding by the primary antibody (Fig.
1D). Within the inner medulla, the
labeling by the AT1R antibody was
associated with the collecting ducts.
|
Specificity of the PCR primers for
AT1AR and
AT1BR.
The AT1R antibody used to
determine the translational sites in the kidney cannot differentiate
between the AT1AR and
AT1BR, because the antigenic
peptide sequence used to generate the polyclonal antibody is identical
to both AT1R subtypes. For this
reason, we designed specific PCR primers to allow us to distinguish the AT1AR and
AT1BR cDNA sequences by gel
electrophoresis. Figure 2 demonstrates the
position of the PCR primers for the
AT1AR and AT1BR and the restriction enzyme
sites (Msp I and
Hinc II) that were used to demonstrate
the specificity of the AT1AR and
AT1BR PCR primers. The antisense
primers were designed within the noncoding region of the
AT1R cDNA sequence due to the low
homology (62%) between each of the
AT1R isoforms. The authenticity of
the AT1R PCR products was
determined by PCR sequencing and restriction enzyme analysis;
Msp I was capable of digesting only
AT1AR PCR products, whereas
Hinc II was capable of only digesting
AT1BR. If any remaining band was
detected at the native size of the PCR products, then we assumed that
the PCR primer pair was not specific for a particular receptor subtype.
|
Microlocalization of
AT1AR and
AT1BR within the rat
kidney.
The RT-PCR analysis of the AT1AR
and AT1BR mRNA in microdissected
tubular and vascular segments is shown in Fig.
3 and summarized in Table
1. The
AT1AR and
AT1BR mRNA was detected in all of
the renal tubular and vascular segments isolated and studied. In
summary, both ANG II type 1 receptor isoforms were found in the
proximal convoluted tubules, medullary TAL (MTAL), and cortical, outer, and inner medullary collecting ducts. In the renal vasculature, the
AT1AR and
AT1BR mRNA was observed in the
glomeruli, OMDVR, afferent arterioles, and arcuate arteries. As
summarized in Table 1, we found positive results (denoted as a
"+") for both AT1R isoforms
in the different segments of the kidney. We performed the RT-PCR assay
for the AT1AR and
AT1BR in six different rat samples
for both the renal vasculature and tubules from the renal medulla to
demonstrate consistent localization of the
AT1R mRNA; we performed three
experiments for the cortical collecting duct and afferent arterioles.
It is important to note that the
AT1AR and
AT1BR mRNA was detected in every
rat sample studied. Each experiment was run with tissue controls where
we used the adrenal gland and liver (100 ng total RNA) to demonstrate
the specificity of the AT1R
primers, where the AT1AR was
present in both tissues, and only the
AT1AR was present in the
liver. In addition, contamination was not evident, as
demonstrated by the absence of detectable bands in the negative
controls: 1) RT-PCR amplification of
the DS; and 2) PCR
amplification of DNase-treated RNA from the MTAL (MTAL RT) or
OMCD (OMCD
RT).
|
|
Angiotensin AT2 Receptor
Immunohistochemistry of
AT2R in rat kidney.
The specificity of the AT2R
antibody provided by our colleagues Nora et al. was determined in their
laboratory by Western blot analysis on membrane-enriched fractions from
the kidney (16,000 g pellet), as
recently reported (26). Using this
AT2R antibody, we found the
translational sites of the AT2R to
be localized in each of the three regions of the rat kidney, which
included the cortex and outer and inner medulla (Fig.
4A).
Higher magnification of the renal cortex revealed that the strongest
labeling of the AT2R was found
within the proximal tubules and distal tubules of the renal cortex,
which includes the collecting ducts (Fig. 4B). Little staining was detected in
the TAL or in the glomeruli. In the renal medulla, the labeling of the
AT2R appeared to be highest in the
collecting ducts (Fig. 4C), with
very little labeling within the vascular bundles. As a
negative control, kidney sections that were incubated with the
AT2R antibody preadsorbed with the competing antigenic peptide did not have any labeling, demonstrating the specificity of the binding by the primary antibody (Fig.
4D).
|
Specificity of the PCR primers for AT2R. The AT2R primers were designed to span both intervening sequences (introns) of the AT2R gene, and the specificity of the AT2R PCR product was verified by PCR sequencing. Moreover, the presence of AT2R mRNA expression in the adrenal gland and aorta and the absence of liver AT2R mRNA is consistent with previously published observations (26, 37), validating the specificity of the AT2R primers (Fig. 2). We performed six experiments for each of the total tissue RNA samples and observed the same qualitative results.
Microlocalization of
AT2R within rat kidney.
The localization of the AT2R mRNA
was determined in microdissected renal tubules and blood vessels from
both the renal cortex and medulla. Figure 5
demonstrates the RT-PCR products for the AT2R in the renal tubules and
vasculature from the present study, and the results are fully
summarized in Table 1. It was determined that the
AT2R mRNA was found in the
proximal convoluted tubule, outer and inner medullary collecting duct,
arcuate artery, and OMDVR. A positive
AT2R signal (denoted as a
"+" in Table 1) in the whole tissue or microdissected tissue was
observed in six different rat kidney samples by gel electrophoresis in
which the AT2R PCR product was
always detected. We also performed three experiments on the cortical
collecting ducts and afferent arterioles, which also detected
AT2R mRNA in every sample
isolated. On the other hand,
AT2R mRNA was not consistently
detected in the MTAL (only one positive result out of six different
MTAL preparations) or in glomeruli (no detectable PCR product
could be observed in any of the six glomerular preparations), so these
renal segments were considered negative (denoted with a ""
in Table 1). Contamination was not evident, as shown by the absence of
detectable bands in the DS and the PCR amplification of
DNase-treated RNA from inner medullary collecting duct. To verify the
authenticity of the AT2R PCR
product, total tissue RNA from the adrenal (100 ng) and liver (1 µg)
were run in each of the assays; adrenals were used as a positive
control for each of the ANG II receptors, and the liver was used as a
negative control for the AT2R.
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The present study was designed to differentiate and localize the angiotensin AT1R subtypes within the rat kidney. Specific PCR primers were designed to allow for the discrimination of the AT1AR, AT1BR, and AT2R by gel electrophoresis. In addition, specific polyclonal antibodies targeted against the AT1R and AT2R were used in immunohistochemistry to demonstrate the translational sites within the kidney.
Localization of the AT1AR and AT1BR Within the Rat Kidney
It is well known that ANG II has both vascular and tubular effects within the rat kidney (18, 25, 29, 40). The immunohistochemical results from the present study showed that the AT1R protein was associated with tubular and vascular structures throughout the kidney, with the strongest labeling being observed in the cortical blood vessels and S3 segment of the proximal tubules in the outer medulla. The results from the present study are consistent with a study by Meister et al. (22) in which the AT1R mRNA was highly localized to the outer medullary proximal tubules using in situ hybridization. Moreover, binding studies with 125I-ANG II in microdissected nephron segments showed binding to be highest in the proximal tubules, with lesser binding in the TAL and collecting ducts (23). Subsequent studies using AT1R and AT2R agonist-selective analogs have demonstrated that the majority of the ANG II binding (>80%) within the kidney is to the AT1R (4, 7, 32, 43). In addition, AT1R distribution has also been found localized to the interstitial cells of the kidney using ANG II binding techniques (43), but the techniques utilized in this study could not ascertain whether interstitial cells were labeled. In all, neither immunohistochemistry nor ANG II binding studies are able to differentiate between the AT1AR and AT1BR, because of the lack of specific AT1R subtype analogs and antibodies.To circumvent this problem, investigators have used RT-PCR to demonstrate the localization of AT1R subtypes within microdissected renal tubules. Terada et al. (39) observed that the AT1R mRNA was present throughout the nephron, which included the proximal tubules, TAL, and collecting ducts. However, the PCR primers used in their study were designed within the coding region of the AT1R where the AT1AR and AT1BR have the highest homology (~92% identical) with each other. Subsequent studies by several investigators began to use restriction enzymes following RT-PCR amplification to distinguish the AT1R isoforms (1). These investigators, however, used this technique only to localize the AT1R isoforms in different regions of the kidney using whole tissue samples. Recent studies by Bouby et al. (2) demonstrated AT1AR and AT1BR mRNA distribution in individual nephron segments, but a number of potential problems could arise from restriction enzyme analysis of PCR products having high homology (greater than 90%), as is the case for the AT1AR and AT1BR. Specifically, the nucleotide mutations can occur during PCR product generation so that a particular restriction enzyme site can be added or removed. Additionally, because restriction enzymes recognize unique palindromic sequences, closely homologous mRNAs may not be digested due to the high PCR cycle numbers. This can result in the formation of AT1AR:AT1BR heteroduplexes, which makes these products unable to be digested. Formation of heteroduplexes is probably the greatest limitation of the restriction enzyme digestion approach (10, 21, 35).
For these reasons, one of the novel contributions of the present study was the development of gene-specific primers that would selectively amplify the AT1R subtypes and thus make the restriction enzyme digestion unnecessary to distinguish the AT1AR from that of AT1BR PCR products. The results of the RT-PCR (as shown in Fig. 2) demonstrated the ability of the present study to design gene-specific primers for highly homologous cDNAs. Further support for the specificity of the PCR primers for selective amplification was obtained using different tissue RNAs, which included the adrenal gland, aorta, and liver. It has been previously reported that the adrenal gland has both isoforms of the AT1R (37) as confirmed in our study. The liver, in contrast, yielded only AT1AR PCR amplification RNA products, but not AT1BR, which confirms observations by others in rats (1) and mice (3). The results of the present study, therefore, showed that the PCR primers, which were designed for the AT1AR and AT1BR, were specific as tested by restriction enzyme digestion and tissue RNA analysis.
The results of our study (summarized in Table 1) demonstrate that all of the tubular segments contain both AT1AR and AT1BR receptor isoforms, including the proximal tubules, TAL, and collecting ducts. In the renal vasculature, the AT1AR and AT1BR mRNA was also detected in the glomerulus, arcuate artery, afferent arterioles, and OMDVR. Studies by Terada et al. (39) demonstrated AT1R mRNA in the arcuate artery and vascular bundles, but the AT1R PCR primers used in that study could not distinguish between the AT1R subtypes. The physiological role of each of these receptors in each of these distinct segments of renal tubules and vessels remains to be determined.
Localization of AT2R Within Rat Kidney
The functional role of the AT2R has not been fully elucidated within the kidney. It is believed that the AT2R is involved in organogenesis, because of its abundant presence during development (36, 37). Initial studies by Grady et al. (7) found that PD-123177, a specific AT2R antagonist, blocked the binding of 125I-[Sar1,Ile8]ANG II during embryogenesis and postnatal development of the rat. In situ hybridization studies found that AT2R mRNA was abundantly found in the rat brain, adrenal glands, and lungs throughout development in the rat, but the AT2R mRNA was detected in the rat kidney only for the first 22 days following parturition (36, 37). Studies by others have indicated that less than 20% of the ANG II binding sites in the adult kidney can be attributed to the AT2R (32, 43).The present study determined that the AT2R mRNA was detected in the adrenal gland and the aorta, but not in the liver. These findings are consistent with previous in situ hybridization and RT-PCR studies (24, 36). In the kidney, we have localized the AT2R mRNA to various tubular and vascular segments from the cortex and medulla, which include the proximal tubules, collecting ducts, arcuate arteries, afferent arterioles, and OMDVR. The presence of AT2R mRNA in afferent arterioles is consistent with the studies of Ruan et al. (32). An absence of AT2R mRNA was observed within the glomerulus and in the MTAL. The absence of glomerular AT2R mRNA in adolescent rats is consistent with previous immunohistochemical (28) and autoradiographic techniques (5) where glomerular AT2R protein was nearly absent in adolescent and adult rats that were fed a normal salt diet. Moreover, the localization of the AT2R mRNA is consistent with the immunohistochemical study performed in the present study, in which we used a specific AT2R antibody. Although the present study demonstrates the presence of the AT2R within the proximal tubules and collecting ducts, further studies need to be performed to address the role(s) of this receptor in the regulation of tubular function.
Functional Roles of the ANG II Receptor Subtypes Within the Renal Vasculature
The role of the ANG II receptor subtypes within the renal vasculature has begun to be elucidated by several investigators. Terada et al. (39) previously demonstrated AT1R mRNA in microdissected arcuate arteries and vasa recta bundles. The transcription of mRNA for both of the AT1R isoforms in the renal vasculature and the supportive immunocytochemical evidence indicates that the vasoconstrictor actions of ANG II on the renal vasculature were related to the stimulation of these receptors. Ikenaga et al. (11), using an isolated split kidney blood perfused juxtamedullary preparation, found that afferent arterioles constricted in the presence of ANG II. The descending vasa recta vessels, which are of particular interest regarding the regulation of medullary blood flow, clearly expressed both isoforms of the AT1R mRNA. The functional significance of these descending vasa recta receptors has been demonstrated by Pallone (29), who has shown that ANG II can cause reductions in luminal diameters of isolated perfused OMDVR through the stimulation of an AT1R. The ability of ANG II to constrict these descending vasa recta could be blocked by the addition of saralasin, an AT1R antagonist. Although isoform-specific AT1R antagonists do not currently exist to determine the functional roles of these receptors, it is evident from the present study that both of these isoforms are widely expressed throughout the renal vasculature and tubules, which may be of functional or pharmacological significance.With regard to the AT2R, the present study has demonstrated that the AT2R mRNA and protein are present within different segments of the cortical and medullary vasculature, including the arcuate artery, afferent arterioles, and OMDVR. The finding of the AT2R within renal vessels is consistent with the previous observation by Ruan et al. (32). The role of the AT2R in the renal vasculature remains to be determined but on a whole tissue basis may have a role in the stimulation of nitric oxide (38). Future studies will need to be performed to address the role of the AT2R within the kidney, particularly within the renal vasculature.
In summary, the present study has demonstrated that AT1R mRNA and protein is found throughout the kidneys of adult Sprague-Dawley rats. The translation sites for this receptor appeared to be most intense in the outer medulla. The design of specific AT1AR and AT1BR primers allowed for the differentiation of the two isoforms of these receptors within microdissected tubular and vascular segments from the renal medulla, which included the TAL, collecting ducts, and OMDVR. The AT2R mRNA and protein was also found widely distributed in the various tubular and vascular segments of the renal cortex and medulla. AT2R mRNA was localized to the proximal tubules, collecting ducts, arcuate arteries, afferent arterioles, and OMDVR. The results indicated that the AT2R mRNA was not readily detectable in the glomerulus or the TAL. It is important to note that in the present study we used techniques which determined the qualitative distribution of the AT1R and AT2R but that future studies need to be performed to quantitate and demonstrate their functional roles within distinct segments of the renal vasculature and tubules.
![]() |
ACKNOWLEDGEMENTS |
---|
We thank Dr. David L. Mattson and Meredith Skelton for critical review of this manuscript, Chibuike Anucha for expert assistance, and Dr. Ai-Ping Zou for helpful discussions.
![]() |
FOOTNOTES |
---|
F. Park was supported by Wisconsin Affiliate American Heart Association Predoctoral Fellowship (96-F-PRE-29). This study was supported by the National Heart, Lung, and Blood Institute Grant HL-29587.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: A. W. Cowley, Jr., Dept. of Physiology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53222.
Received 31 July 1998; accepted in final form 30 April 1999.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Bouby, N. L.,
L. Bankir,
and
C. Llorens-Cortes.
Type 1 angiotensin II receptor subtypes in kidney of normal and salt-sensitive hypertensive rats.
Hypertension
27:
392-398,
1996
2.
Bouby, N.,
A. Hus-Citharel,
J. Marchetti,
L. Bankir,
P. Corvol,
and
C. Llorens-Cortes.
Expression of type 1 angiotensin II receptor subtypes and angiotensin II-induced calcium mobilization along the rat nephron.
J. Am. Soc. Nephrol.
8:
1658-1667,
1997[Abstract].
3.
Burson, J. M.,
G. Aguilera,
K. W. Gross,
and
C. D. Sigmund.
Differential expression of angiotensin receptor 1A and 1B in mouse.
Am. J. Physiol.
267 (Endocrinol. Metab. 30):
E260-E267,
1994
4.
Chatziantoniou, C.,
and
W. J. Arendshorst.
Angiotensin receptor sites in renal vasculature of rats developing genetic hypertension.
Am. J. Physiol.
265 (Renal Fluid Electrolyte Physiol. 34):
F853-F862,
1993
5.
Ciuffo, G. M.,
M. Viswanathan,
A. M. Seltzer,
K. Tsutsumi,
and
J. M. Saavedra.
Glomerular angiotensin II receptor subtypes during development of rat kidney.
Am. J. Physiol.
265 (Renal Fluid Electrolyte Physiol. 34):
F264-F271,
1993
6.
Du, Y.,
A. Yao,
D. Guo,
T. Inagami,
and
D. H. Wang.
Differential regulation of angiotensin II receptor subtypes in rat kidney by low dietary sodium.
Hypertension
25:
872-877,
1995
7.
Grady, E. F.,
L. A. Sechi,
C. A. Griffin,
M. Schambelan,
and
J. E. Kalinyak.
Expression of AT2 receptors in the developing rat fetus.
J. Clin. Invest.
88:
921-933,
1991[Medline].
8.
Guo, D. F.,
and
T. Inagami.
The genomic organization of the rat angiotensin II receptor AT1B.
Biochim. Biophys. Acta
1218:
91-94,
1994[Medline].
9.
Harrison-Bernard, L. M.,
L. G. Navar,
M. M. Ho,
G. P. Vinson,
and
S. S. El-Dahr.
Immunohistochemical localization of ANG II AT1 receptor in adult rat kidney using a monoclonal antibody.
Am. J. Physiol.
273 (Renal Physiol. 42):
F170-F177,
1997
10.
Henley, W. N.,
K. E. Schuebel,
and
D. A. Nielsen.
Limitations imposed by heteroduplex formation on quantitative RT-PCR.
Biochem. Biophys. Res. Commun.
226:
113-117,
1996[Medline].
11.
Ikenaga, H.,
R. W. Fallet,
and
P. K. Carmines.
Basal nitric oxide production curtails arteriolar vasoconstrictor responses to ANG II in the rat kidney.
Am. J. Physiol.
271 (Renal Fluid Electrolyte Physiol. 40):
F365-F373,
1996
12.
Iwai, N.,
J. H. Weil,
S. Chaki,
F. Konishi,
S. Bardian,
C. Tibbetts,
K. Sasaki,
M. Hasegawa,
Y. Matsuda,
and
T. Inagami.
Rat angiotensin II receptor: cDNA sequence and regulation of the gene expression.
Biochem. Biophys. Res. Commun.
177:
299-304,
1991[Medline].
13.
Jacobs, L. S.,
and
J. G. Douglas.
Angiotensin II type 2 receptor subtype mediates phospholipase A2-dependent signaling in rabbit proximal tubular epithelial cells.
Hypertension
28:
663-668,
1996
14.
Kakar, S. S.,
J. C. Sellers,
D. C. Devor,
L. C. Musgrove,
and
J. D. Neill.
Angiotensin II type-1 receptor subtype cDNAs: differential tissue expression and hormonal regulation.
Biochem. Biophys. Res. Commun.
183:
1090-1096,
1992[Medline].
15.
Kakinuma, Y.,
A. Fogo,
T. Inagami,
and
I. Ichikawa.
Intrarenal localization of angiotensin II type 1 receptor mRNA in the rat.
Kidney Int.
43:
1229-1235,
1992.
16.
Kambayahi, Y.,
S. Bardhan,
K. Takahashi,
S. Tsuzki,
H. Inui,
T. Hamakubo,
and
T. Inagami.
Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition.
J. Biol. Chem.
268:
24543-24546,
1993
17.
Koike, G.,
E. S. Winer,
H. Horiuchi,
D. M. Brown,
C. Szpirer,
V. J. Dzau,
and
H. J. Jacob.
Cloning, characterization, and genetic mapping of the rat type 2 angiotensin II receptor gene.
Hypertension
26:
998-1002,
1995
18.
Liu, F. Y.,
and
M. G. Cogan.
Angiotensin II stimulation of hydrogen ion secretion in the rat early proximal tubule. Modes of action, mechanism, and kinetics.
J. Clin. Invest.
82:
601-607,
1988[Medline].
19.
Llorens-Cortes, C.,
B. Greenberg,
H. Huang,
and
P. Corvol.
Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis.
Hypertension
24:
538-548,
1994[Abstract].
20.
Lo, M.,
K. Liu,
P. Lantelme,
and
J. Sassard.
Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rat.
J. Clin. Invest.
95:
1394-1397,
1995[Medline].
21.
McCulloch, R. K.,
C. S. Choong,
and
D. M. Hurley.
An evaluation of competitor type and size for use in the determination of mRNA by competitive RT-PCR.
PCR Methods Applicat.
4:
219-226,
1995.
22.
Meister, B.,
A. Lippoldt,
B. Bunnemann,
T. Inagami,
D. Ganten,
and
K. Fuxe.
Cellular expression of angiotensin type-1 receptor mRNA in the kidney.
Kidney Int.
44:
331-336,
1993[Medline].
23.
Mujais, S. K.,
S. Kauffman,
and
A. I. Katz.
Angiotensin II binding sites in individual segments of the rat nephron.
J. Clin. Invest.
77:
315-318,
1986[Medline].
24.
Nakajima, M.,
M. Mukoyama,
R. E. Pratt,
M. Horiuchi,
and
V. J. Dzau.
Cloning of cDNA and analysis of the gene for mouse angiotensin II type 2 receptor.
Biochem. Biophys. Res. Commun.
197:
393-399,
1993[Medline].
25.
Navar, L. G.,
E. W. Inscho,
S. A. Majid,
J. D. Imig,
L. M. Harrison-Bernard,
and
K. D. Mitchell.
Paracrine regulation of the renal microcirculation.
Physiol. Rev.
76:
425-536,
1996
26.
Nora, E. H.,
D. H. Munzenmaier,
F. M. Hansen-Smith,
J. H. Lombard,
and
A. S. Greene.
Localization of the angiotensin II type 2 receptor in the microcirculation of skeletal muscle.
Am. J. Physiol.
275 (Heart Circ. Physiol. 44):
H1395-H1403,
1998
27.
Oliverio, M. I.,
C. F. Best,
H. S. Kim,
W. J. Arendshorst,
O. Smithies,
and
T. M. Coffman.
Angiotensin II responses in AT1A receptor-deficient mice: a role for AT1B receptors in blood pressure regulation.
Am. J. Physiol.
272 (Renal Physiol. 41):
F515-F520,
1997
28.
Ozono, R.,
Z. Q. Wang,
A. F. Moore,
T. Inagami,
H. M. Siragy,
and
R. M. Carey.
Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney.
Hypertension
30:
1238-1246,
1997
29.
Pallone, T. L.
Vasoconstriction of outer medullary vasa recta by angiotensin II is modulated by prostaglandin E2.
Am. J. Physiol.
266 (Renal Fluid Electrolyte Physiol. 35):
F850-F857,
1994
30.
Park, F.,
D. L. Mattson,
L. A. Roberts,
and
A. W. Cowley, Jr.
Evidence for the presence of smooth muscle -actin within pericytes of the renal medulla.
Am. J. Physiol.
273 (Regulatory Integrative Comp. Physiol. 42):
R1742-R1748,
1997
31.
Paxton, W. G.,
M. Runge,
C. Horaist,
C. Cohen,
R. W. Alexander,
and
K. E. Bernstein.
Immunohistochemical localization of rat angiotensin II AT1 receptor.
Am. J. Physiol.
264 (Renal Fluid Electrolyte Physiol. 33):
F989-F995,
1993
32.
Ruan, X.,
C. Wagner,
C. Chatziantoniou,
A. Kurtz,
and
W. J. Arendshorst.
Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
J. Clin. Invest.
99:
1072-1081,
1997
33.
Sandberg, K.,
H. Ji,
A. J. L. Clark,
H. Shapira,
and
K. J. Catt.
Cloning and expression of novel angiotensin II receptor subtype.
J. Biol. Chem.
267:
9455-9458,
1992
34.
Schmid, C.,
H. Castrop,
J. Reitbauer,
D. Bruna,
and
A. Kurtz.
Dietary salt intake modulates angiotensin II type 1 receptor gene expression.
Hypertension
29:
923-929,
1997
35.
Schneeberger, C.,
P. Speiser,
F. Kury,
and
R. Zeillinger.
Quantitative detection of reverse transcriptase-PCR products by means of a novel and sensitive DNA stain.
PCR Methods Applicat.
4:
234-238,
1995.
36.
Shanmugam, S.,
C. Llorens-Cortes,
E. Clauser,
P. Corvol,
and
J. M. Gasc.
Expression of angiotensin II AT2 receptor mRNA during development of rat kidney and adrenal gland.
Am. J. Physiol.
268 (Renal Fluid Electrolyte Physiol. 37):
F922-F930,
1995
37.
Shanmugam, S.,
and
K. Sandberg.
Ontogeny of angiotensin II receptors.
Cell Biol. Int.
20:
169-176,
1996[Medline].
38.
Siragy, H. M.,
and
R. M. Carey.
The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
J. Clin. Invest.
100:
264-269,
1997
39.
Terada, Y.,
K. Tomita,
H. Nonoguchi,
and
F. Marumo.
PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney.
Kidney Int.
43:
1251-1259,
1993[Medline].
40.
Timmermans, P. B. M. W. M.,
P. C. Wong,
A. T. Chiu,
W. F. Herblin,
P. Benfield,
D. J. Carini,
R. J. Lee,
R. R. Wexler,
J. A. M. Saye,
and
R. D. Smith.
Angiotensin II receptors and angiotensin II receptor antagonists.
Pharmacol. Rev.
45:
205-251,
1993[Medline].
41.
Tufro-McReddie, A.,
L. M. Romano,
J. M. Harris,
L. Ferder,
and
R. A. Gomez.
Angiotensin II regulates nephrogenesis and renal vascular development.
Am. J. Physiol.
269 (Renal Fluid Electrolyte Physiol. 38):
F110-F115,
1995
42.
Wright, P. A.,
M. B. Burg,
and
M. A. Knepper.
Microdissection of kidney tubule segments.
Methods Enzymol.
191:
226-231,
1990[Medline].
43.
Zhou, J.,
D. Alcorn,
A. M. Allen,
and
F. A. O. Mendelsohn.
High resolution localization of angiotensin II receptors in rat renal medulla.
Kidney Int.
42:
1372-1380,
1992[Medline].